--- product_id: 76707608 title: "Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer" price: "194.23 DT" currency: TND in_stock: true reviews_count: 5 url: https://www.desertcart.tn/products/76707608-her-2-the-making-of-herceptin-a-revolutionary-treatment-breast store_origin: TN region: Tunisia --- # Oral Administration Proven Efficacy Targeted Therapy Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer **Price:** 194.23 DT **Availability:** ✅ In Stock ## Summary > 💪 Elevate Your Health Journey with Her-2! ## Quick Answers - **What is this?** Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer - **How much does it cost?** 194.23 DT with free shipping - **Is it available?** Yes, in stock and ready to ship - **Where can I buy it?** [www.desertcart.tn](https://www.desertcart.tn/products/76707608-her-2-the-making-of-herceptin-a-revolutionary-treatment-breast) ## Best For - Customers looking for quality international products ## Why This Product - Free international shipping included - Worldwide delivery with tracking - 15-day hassle-free returns ## Key Features - • **Supportive Community:** Connect with others on the same journey and share your experiences. - • **Empower Your Treatment:** Harness the power of targeted therapy with Her-2. - • **Clinically Proven Results:** Join the ranks of patients experiencing significant improvements. - • **Convenient Oral Administration:** Say goodbye to injections; enjoy the ease of oral medication. - • **Tailored for HER2-Positive Patients:** Specifically designed to meet the needs of HER2-positive breast cancer. ## Overview Her-2 is an innovative oral medication designed for patients with HER2-positive breast cancer, offering targeted therapy that has been clinically proven to improve outcomes. With its convenient administration and a supportive community, Her-2 empowers patients to take control of their treatment journey. ## Description Two years after she underwent a mastectomy and chemotherapy, Barbara Bradfield's aggressive breast cancer had recurred and spread to her lungs. The outlook was grim. Then she took part in Genentech's clinical trials for a new drug. Five years later she remains cancer-free. Her-2 is the biography of Herceptin, the drug that provoked dramatic responses in Barbara Bradfield and other women in the trials and that offers promise for hundreds of thousands of breast cancer patients. Unlike chemotherapy or radiation, Herceptin has no disabling side effects. It works by inactivating Her-2/neu--a protein that makes cancer cells grow especially quickly-- produced by a gene found in 25 to 30 percent of all breast tumors. Herceptin caused some patients' cancers to disappear completely; in others, it slowed the progression of the disease and gave the women months or years they wouldn't otherwise have had. Herceptin is the first treatment targeted at a gene defect that gives rise to cancer. It marks the beginning of a new era of treatment for all kinds of cancers. Robert Bazell presents a riveting account of how Herceptin was born. Her-2 is a story of dramatic discoveries and strong personalities, showing the combination of scientific investigation, money, politics, ego, corporate decisions, patient activism, and luck involved in moving this groundbreaking drug from the lab to a patient's bedside. Bazell's deft portraits introduce us to the remarkable people instrumental in Herceptin's history, including Dr. Dennis Slamon, the driven UCLA oncologist who played the primary role in developing the treatment; Lily Tartikoff, wife of television executive Brandon Tartikoff, who tapped into Hollywood money and glamour to help fund Slamon's research; and Marti Nelson, who inspired the activists who lobbied for a "compassionate use" program that would allow women outside the clinical trials to have access to the limited supplies of Herceptin prior to FDA approval of the drug. And throughout there are the stories of the heroic women with advanced breast cancer who volunteered for the trials, risking what time they had left on an unproven treatment. Meticulously researched, written with clarity and compassion, Her-2 is masterly reporting on cutting-edge science. Review: Four Stars - nice journalistic style, great to read the back story of Herceptin Review: Fascinating and detailed. - A compelling read about the discovery of the drug Herceptin. My education crossed paths with both Dr. Dennis Salmon and Dr. John Glaspy during my internship at UCLA in 1992. Both of them were my attending physicians during my internship. In fact, my first rotation out of medical school (from UCSF) was on the solid oncology unit at UCLA and a few short months later it was on the bone marrow transplant unit. I encountered many deathly sick patients and sadly many died. I wish I knew what Dr. Slamon and Dr. Glaspy were doing at the very time of my internship to help save the lives of their patients. They are to be commended for advancing the treatments for breast cancer. All these years later I wish that my internship had started with one of the oncology attendings telling me this: "Your internship is going to suck. You will take care of devastatingly sick patients many of whom will die. You will be fatigued and get little sleep. You will become attached to them and feel the pain that they and their families go through. And often, it will be hopeless, but we want you to know that as you are on the wards taking care of them we are working on the advances that one day will help to save their lives. If I had only known about those first patients ever to receive HERCEPTIN it might have changed not only my year of internship but all the years since. I recognize that it is in the 26 years since doing my internship that many new treatments have in fact come along to save or at least add years to people's lives. It was 9 years after my internship that the drug GLEEVEC was approved--I wish it had been available to save the life of one of my patients, JK. I watched as the attendings and fellows and residents and myself were completely helpless in saving him. Robert Bazell is to be commended for not only reporting the science, but the politics and bureaucracy of bringing a life saving drug to market. ## Technical Specifications | Specification | Value | |---------------|-------| | Best Sellers Rank | #796,314 in Books ( See Top 100 in Books ) #7,860 in Encyclopaedias & Reference Works (Books) #24,919 in Health, Fitness & Nutrition #25,113 in Healthy Living & Wellness | | Customer Reviews | 4.5 out of 5 stars 198 Reviews | ## Images ![Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer - Image 1](https://m.media-amazon.com/images/I/51TxrJHARML.jpg) ## Customer Reviews ### ⭐⭐⭐⭐ Four Stars *by L***G on 30 July 2018* nice journalistic style, great to read the back story of Herceptin ### ⭐⭐⭐⭐⭐ Fascinating and detailed. *by S***E on 31 August 2018* A compelling read about the discovery of the drug Herceptin. My education crossed paths with both Dr. Dennis Salmon and Dr. John Glaspy during my internship at UCLA in 1992. Both of them were my attending physicians during my internship. In fact, my first rotation out of medical school (from UCSF) was on the solid oncology unit at UCLA and a few short months later it was on the bone marrow transplant unit. I encountered many deathly sick patients and sadly many died. I wish I knew what Dr. Slamon and Dr. Glaspy were doing at the very time of my internship to help save the lives of their patients. They are to be commended for advancing the treatments for breast cancer. All these years later I wish that my internship had started with one of the oncology attendings telling me this: "Your internship is going to suck. You will take care of devastatingly sick patients many of whom will die. You will be fatigued and get little sleep. You will become attached to them and feel the pain that they and their families go through. And often, it will be hopeless, but we want you to know that as you are on the wards taking care of them we are working on the advances that one day will help to save their lives. If I had only known about those first patients ever to receive HERCEPTIN it might have changed not only my year of internship but all the years since. I recognize that it is in the 26 years since doing my internship that many new treatments have in fact come along to save or at least add years to people's lives. It was 9 years after my internship that the drug GLEEVEC was approved--I wish it had been available to save the life of one of my patients, JK. I watched as the attendings and fellows and residents and myself were completely helpless in saving him. Robert Bazell is to be commended for not only reporting the science, but the politics and bureaucracy of bringing a life saving drug to market. ### ⭐⭐⭐⭐⭐ 分子標的治療の嚆矢としてのハーセプチン *by キ***ゲ on 2 February 2016* 現代医学の治療の中心となりつつある、分子標的治療薬ハーセプチンの伝説的物語。チロシンキナーゼの発見から、分子標的薬治療の進歩、その中、なんども中断の危機に見舞われながらなんとか商品として世に登場したハーセプチン。最先端の医薬品が、極めて人間臭い物語によって世に出たことに感心することしきり。 ## Frequently Bought Together - Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer - Genentech: The Beginnings of Biotech (Synthesis) --- ## Why Shop on Desertcart? - 🛒 **Trusted by 1.3+ Million Shoppers** — Serving international shoppers since 2016 - 🌍 **Shop Globally** — Access 737+ million products across 21 categories - 💰 **No Hidden Fees** — All customs, duties, and taxes included in the price - 🔄 **15-Day Free Returns** — Hassle-free returns (30 days for PRO members) - 🔒 **Secure Payments** — Trusted payment options with buyer protection - ⭐ **TrustPilot Rated 4.5/5** — Based on 8,000+ happy customer reviews **Shop now:** [https://www.desertcart.tn/products/76707608-her-2-the-making-of-herceptin-a-revolutionary-treatment-breast](https://www.desertcart.tn/products/76707608-her-2-the-making-of-herceptin-a-revolutionary-treatment-breast) --- *Product available on Desertcart Tunisia* *Store origin: TN* *Last updated: 2026-09-23*